Animal healthcare pharma producer ECO Animal Health Group announced receiving Health Ministry approval to sell Aivlosin in Egypt. The medication is used “for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption.” ECO Chairman Peter Lawrence said “Egypt is the second most important egg producing country in the Middle East and is ranked just outside the global top 20 for commercial layers.”
More from Enterprise
The National Bank of Egypt and Banque Misr just hiked rates on CDs — moves that could see the EGP gain against the USD
NBE and BM both hiked rates on CDs by 125…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Swvl is not dropping off of Nasdaq just yet, as company turns to the black in 2025
The company turned a profit last year, allowing it to…
IBF & Company doubles down on logistics with Techno Metal acquisition
Plus: Lucky lands USD 23 mn in Series B round,…